Agent View

Machine representations

Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.

Canonical entity
alpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf
Schema
alpha.governance.entity.public.v1
Last reviewed
2026-09-13T04:45:36.671502+00:00
Verification
source_reported
Ownership
unclaimed

Markdown

https://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc.md
Open Markdown

Kiniksa Pharmaceuticals International, plc

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

FieldValue
Representationalpha-profile-markdown-v3
ProtocolAlpha Governance Facts Protocol 0.1
Schemaalpha.governance.entity.public.v1
Record versionpublic-1
Canonical entityalpha:company:9011f721-f68e-4a71-b1b5-e505201f81cf
Entity typeCompany
Canonical URLhttps://registry.alpha.ac/companies/kiniksa-pharmaceuticals-international-plc
PublicationPUBLISHED
Verificationsource_reported
Verification schemaalpha-verification-states-v1
Ownershipunclaimed
Published claims19
Claims under review1
Evidence records3
Conflicts0
Conflicts in internal review0
Observed2026-09-13T04:45:36.671502+00:00
Last reviewed2026-09-13T04:45:36.671502+00:00

Identity

  • Legal name: Kiniksa Pharmaceuticals International, plc
  • Display name: Kiniksa Pharmaceuticals International, plc

Leadership

  • Barry D. Quart, Pharm.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Felix J. Baker, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • G. Bradley Cole: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Kimberly J. Popovits: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Meredith S. Boyd: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Richard S. Levy, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Sanj K. Patel: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Stephen R. Biggar, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Thomas R. Malley: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Tracey L. McCain: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:2.
  • Eben Tessari: Executive Vice President and Chief Strategy Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:3.
  • John F. Paolini: Executive Vice President and Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:3.
  • Mark Ragosa: Executive Vice President and Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:3.
  • Michael Megna: Senior Vice President, Chief Accounting Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:3.
  • Ross Moat: Executive Vice President and Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:3.
  • Sanj K. Patel: Chief Executive Officer and Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:3.

Roles

  • PUBLISHED

Governance

  • NOT_ASSERTED

Board committees

  • PUBLISHED

Financials

  • NOT_ASSERTED

Workforce

  • NOT_ASSERTED

Market and index context

  • PUBLISHED

Legal Name

  • Kiniksa Pharmaceuticals International, plc. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:1.

Headquarters

  • US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

  • Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:1.

Published Fact

  • US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:9011f721-f68e-4a71-b1b5-e505201f81cf:1.

Coverage states

FieldValue
IdentityPUBLISHED
BusinessPUBLISHED
LeadershipPUBLISHED
Board and committeesPUBLISHED
GovernanceNOT_ASSERTED
FinancialsNOT_ASSERTED
WorkforceNOT_ASSERTED
OwnershipNOT_ASSERTED
RatingsNOT_PUBLISHED
Market and index contextPUBLISHED

Public sources

Rights

FieldValue
public_retrievalallowed
agent_retrievalallowed
redistributionnot_granted
model_trainingnot_granted
commercial_usenot_specified
relationship_pathfindingnot_granted
direct_contactnot_granted

Limitations

  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations